The Politics Of Health: Feature ArticleThe Delusion of Bone DrugsFriday, January 11, 2008Byron Richards, CCN Women across the country are being duped to consume billions of dollars worth of bone poisons under the false pretense that if they take them long enough they will not develop osteoporosis. Even the FDA is becoming alarmed by the side effects of these bone drugs – a rather stunning event considering the FDA hardly ever acts to cast suspicion on the propaganda put out by a Big Pharma blockbuster class of drugs being slickly marketed for prevention. The drugs in question are known as bisphosphonates. The biggest selling drug in this class is called Fosamax, made by Merck – the very same company that killed thousands of Americans with Vioxx while hiding cardiovascular risks from the FDA and patients. Does anyone trust them? Other commonly recognized names are Actonel (Proctor and Gamble) and Boniva (Roche and GlaxoSmithKline). Collectively these drugs had $4.3 billion in U.S. sales during 2006 (27 million prescriptions). A recent flood of negative information about these drugs is finally coming to light, including an alarming FDA pain warning, the risk for atrial fibrillation, the numerous cases of rotting jaw bones, and a new major study that concludes after 15 years of widespread use there is not enough science to show if the medications are safe or effective. Sure bone health is extremely important; however, taking bisphosphonate bone drugs does not produce stronger or healthier bones – quite to the contrary. The FDA Warning – Severe Pain from Bone Drugs On Monday, January 7, 2008, the FDA issued a warning on bisphosphonate drugs saying that there is a possibility of “severe and sometimes incapacitating bone, joint, and/or muscle (musculoskeletal) pain in patients taking bisphosphonates.” The FDA explained that the pain “may occur within days, months, or years after starting bisphosphonates. Some patients have reported complete relief of symptoms after discontinuing the bisphosphonate, whereas others have reported slow or incomplete resolution.” Translated to English this means that any woman experiencing any bone, joint, or muscle pain of any kind since starting a bisphosphonate bone drug, even if the pain started several years after first taking the drug, should work with her prescribing physician to immediately discontinue use of the drug to see if the pain stops or gets better. Of course, taking statins to lower cholesterol can also cause severe muscle pain and many women are on both drugs – a double whammy. Think about it for a minute – how could a drug that is supposed to be good for bones cause incapacitating bone pain in anyone? Since the FDA has trouble understanding how the drugs it has approved behave in the human body, they had no explanation as to why bone drugs were causing such horrendous pain. Thus, I will be happy to explain the nature of the problem. Bisphosphonates are Highly Inflammatory Drugs Bisphosphonates are a caustic chemical. They damage any human tissue they come in contact with. They have been proven to induce inflammation by direct contact with body surfaces and they have been proven to set in motion a chain reaction of inflammatory events. Indeed, one way they work is by poisoning to death a type of bone cell known as an osteoclast. The medical profession thinks it is a good idea to poison osteoclasts because there are too many of them in people with accelerated bone loss. Never do they bother asking why there are too many and treat the source of the problem. Even though osteoclasts are a normal bone cell required for healthy bone metabolism, the pushers of these poisons have come up with an excuse to perform a type of chemotherapy on bone cells, often in the name of preventive health! It has been proven beyond any doubt that these drugs cause swollen bone due to their highly inflammatory nature. In fact, the unreliable and inaccurate X-Ray-generated pictures doctors claim are better bone density after a person has been taking these drugs for a while are actually pictures of swollen and inflamed bone that is being chaotically disorganized and weakened by these drugs. A sprained ankle looks bigger than a normal ankle, so does a sprained bone. It is worth noting that in addition to the fact the pictures are of swollen bones, the pictures themselves are never an accurate measure of true bone density in any person. These bone pictures are referred to as Dual energy X-ray Absorptiometry (DXA). The flaws include a huge variance in human operator skill and the inability of the machine to judge bone depth, thus all pictures are guesses anyway. The best-guess reference charts are easily skewed by tall people, short people, thick-boned people – and the lack of skill of the machine operator. The pictures cannot show bone strength or bone integrity (a convenient shortcoming for bisphosphonate drugs). Because bisphosphonates also glue calcium in an abnormal manner onto bone, the mirage is that there appears to be more density – true smoke and mirrors. Numerous studies with bone biopsy show that bisphosphonate-treated bone is actually swollen, chaotically disorganized, and weaker than healthy bone. If you would like to understand the details of this issue, as well as basic bone metabolism, you may read for free Chapter 18: The Illusion of Bone Drugs, from my book Fight for Your Health – Exposing the FDA’s Betrayal of America. Also, included in the appendix are numerous references documenting all of the many side effects of these drugs up through 2006. The FDA is now warning that at some point while taking these drugs there can be intense and even debilitating pain. This is obviously due to the caustic and highly inflammatory nature of these drugs. Here is a question for the medical profession. Since it is now clearly understood that excessive inflammation is part of the primary cause of every single disease of aging – what makes you think you are helping the overall health of anyone by giving them a highly inflammatory bisphosphonate drug for a number of years? Of course, doctors may warn their patients to walk around after taking these drugs and not lay down. This is because bisphosphonates are so caustic and inflammatory to the digestive system that they may cause significant damage to the lining of the intestinal tract. In fact, the drug is only 1% absorbed which leaves 99% of the poison to batter the digestive lining. The drug even comes with warnings not to give it to people with digestive problems – a warning that is routinely ignored by many prescribing physicians. The FDA issued its pain warning because doctors are also ignoring that bisphosphonates are a likely cause of a terrible inflammatory pain which may even start long after first taking the drug. Doctors have been treating this pain with pain killers, the typical style of the drug-dispensing paradigm governing “modern” medicine – give one drug to offset the side effects of another (IQ=70). If we had to stretch the imagination of these brilliant men of medicine then possibly they might conceive of the notion that once this caustic drug is absorbed and before it arrives at the bones to work its inflammatory damage in the name of “health,” it must go through the circulation and past the heart. Would you like to guess what the drug is doing while it is in the cardiovascular system? Are doctors somehow not aware that filling the arteries with plaque, which leads to heart attacks and strokes, is clearly an inflammatory disease? Bisphosphonates Increase the Risk for Atrial Fibrillation Since October 1, 2007 the FDA has also announced that it is reviewing the link between bisphosphonate drugs and atrial fibrillation (a potentially life-threatening heart problem). The FDA updated its posting about this issue on January 7, 2008 when it released its pain warning. In essence, the FDA says it is confused about the issue and trying to study the matter. This is simply another instance of FDA incompetence and failure to do its job. Back in 1997 it was clear to the FDA that a Merck study showed a 50% increased risk in serious atrial fibrillation from Fosamax. The FDA did not demand that Merck conduct a specific post-marketing safety analysis relating to atrial fibrillation. This was a major failure on the part of the FDA to protect the public. Thus, the only data the FDA can review are studies regarding bisphosphonates that may report atrial fibrillation but are not designed to test for it. The FDA also has its MedWatch program, but most physicians and patients don’t link the two issues so don’t know to report it. The FDA is only now becoming interested in the issue as a new type of powerful bisphosphonate that involves a once a year intravenous infusion are showing a 150% increased risk for atrial fibrillation. This is obviously a higher potency of the drug in the circulation, giving its highly inflammatory and caustic characteristics more of a chance to weaken the heart in one major “blast attack.” If this therapy catches on with women atrial fibrillation problems will triple. The FDA says it plans to drag its feet on the issue for another 10 months, at which point it is likely to say it does not have enough data to know for sure one way or the other – great job FDA. It appears that any woman taking bisphosphonates who has a concern about heart health should think twice – considering the FDA has no clue what the real risks are. While the risk of a problem may be only 0.5% to 1% of those taking the drug, that can easily translate to 15,000 – 30,000 cases of serious atrial fibrillation per year based on the large numbers of women on these medications. Of course, if a patient should develop atrial fibrillation due to a bisphosphonate drug then their doctors will put them on the rat poison called Coumadin (Warfarrin). This drug has been shown to increase the risk of fractures by 25% after one year of use. Atrial fibrillation is not the only potential cardiovascular risk. Science shows that bisphosphonates activate adhesion molecules which are known to initiate plaque formation in arteries. A mouse study shows that bisphosphonates trigger the rupturing of atherosclerotic plaque – which causes strokes and heart attacks in humans. The FDA is not demanding the makers of these drugs prove they are safe for cardiovascular health and that they do not contribute to plaque formation in the arteries. Once again, the FDA has left the public groping in the dark. We already know that Merck does not disclose heart risks of its drugs to the FDA or the public, as clearly proven by the Vioxx case. Rotting Jaw Bone Here is another simple question. How can a drug that rots out someone’s jaw bone possibly be good for the bones of any person? Rotting jaw bone, otherwise known as osteonecrosis of the jaw, became a hot topic back in the summer of 2005 when it was first widely reported that patients on intravenous bisphosphonates ran the risk of developing this debilitating jaw condition, especially if they needed some dental work done. As the drama unfolded patients taking oral Fosamax began reporting their deteriorating jaw bone problems, now known as Fossie jaw. Merck currently faces a number of lawsuits on the issue. Individuals who need any kind of significant dental work should think twice before taking a bisphosphonate drug, as their jaw may have trouble healing and teeth may have trouble staying firmly in place. While having one’s jaw rot completely out is a horrendous problem, it is far more likely that many people are experiencing jaw-related stress and wear from these drugs. Any person developing TMJ, jaw pain, or any kind of dental problem after being on a bisphosphonate should be very concerned. Japanese researchers warned of this problem back in 2000 and the need to be cautious for jaw health in patients taking Fosamax, but the FDA was not paying any attention. In fact, the FDA let millions of American women take this drug to prevent osteoporosis when the drug never even went through a normal approval process for its common uses in today’s world (it was only approved for serious bone disease). This is rather shocking to say the least – but true. How Bisphosphonate Bone Drugs Work
The bisphosphonate bone drugs work in two main ways:
Once bisphosphonates arrive at bone they are stuck there forever, as a completely abnormal substance residing within and on the bone. The human body has no enzyme system that can break them down. Thankfully, after one year the biological activity of the poison is reduced; however, it is still stuck in the bone indefinitely. It is not a trivial issue to give a patient a toxic drug that accumulates in bones and is highly active even after it is stopped, which explains why some of the patients did not get rid of their pain even after discontinuing the drug. Such a therapy may have some advantages in a situation of very poor health wherein a person is rapidly losing bone. The idea is that it is better to have some bone, regardless of its true condition, compared to no bone. Indeed, these drugs were first approved for diseases of rapid bone loss, such as Paget’s disease. In such high risk cases it can be demonstrated that the risk of fracture can be reduced. In other words, bones glued together with Fosamax may be better than really weak bones in horrid health. However, healthy bone has a fairly high activity of osteoclasts (the demo crew) and osteoblasts (bone building carpenter cells), operating in balance. By killing osteoclasts all that happens is old bone is left in place and new bone can’t properly form due to all the clutter in the way – resulting in highly disorganized and abnormal bone matrix. This is a far cry from healthy bones. If a healthy woman does this for 5-10 years in an effort to ward off osteoporosis it is pretty clear that she has been conned – and actually worsened her bone health. A Comprehensive Review of Bone Drug Effectiveness A major study was recently conducted in an effort to compare these bone drugs to other drug options to see which drugs or therapies actually produced the best patient outcomes in the real world. The goal of such research is to help prescribing physicians know what options are best based on scientific review. The researchers found that bisphosphonates were no better than anything else – a disturbing finding in and of itself. The research was reported in a January 2008 issue of the Annals of Internal Medicine (full article here). The conclusion of the study states “Although good evidence suggests that many agents are effective in preventing osteoporotic fractures, data are insufficient to determine the relative efficacy or safety of these agents.” This conclusion, worded to be as politically correct as could be contrived in a drug-related journal, is a shocking indictment of the ineptitude of the FDA. How could a drug be in use for 15 years, with billions of dollars of sales per year, and the FDA has never demanded proof that the drug was safe or effective??? The bisphosphonates, as I explain above, work best in people with serious bone health issues wherein bones glued together with bisphosphonates are better than extremely fragile bones. Here we can see a slight reduction in fracture in a difficult patient population, which is a valid use of medicine. Keep in mind that there are not enough people in this high risk group for Big Pharma to make a profit. Big Pharma has to convince low risk people (millions of baby boomers) to take these drugs for 10 years as a prevention tool – a marketing campaign that has been in full swing for a number of years (a low risk population). When you look deep within this study about the use of Fosamax in this low risk population the study authors state Fosamax in this group “may in fact have had no effect on or even have increased the risk for fracture.” Not exactly a glowing report for a drug that is being crammed down the throats of generally healthy women in the billions of dollars per year. And far different than the fudged conclusion the media is likely to read. An unbiased conclusion of this study would be “Various drug therapies, including bisphosphonates, may be able to reduce the risk of osteoporotic fractures in some patients in the high risk category – though safety and efficacy is not clear. In the low risk category there is no evidence of long-term benefit, and safety and efficacy is also not clear – there may even be a risk for fracture increase.” Bone Health is Important Bone health is very important. There are many dramatic discoveries relating to bones and how to help them, all centered on safe and natural options to improve health. The new science shows that the reason there are too many osteoclasts causing bone loss is because of an underlying inflammatory problem in the bones – part of an overall inflammatory wear and tear trend. When this trend occurs at a normal pace it is considered routine aging. When this inflammatory trend is accelerated then the weakest link in the chain manifests as a disease (heart disease, cancer, Alzheimer’s, osteoporosis, etc).
It is shear idiocy to treat an inflammatory bone problem with an inflammatory bone drug, especially for prevention. Numerous nutrients are now proven to directly lower inflammation in bone, thus naturally promoting the healthy balance and function of osteoclasts and osteoblasts. There are no shortcuts or quick fixes for bone health. Stress is highly inflammatory and a major problem. The foundation of a proper plan is a good diet, maintaining proper body weight, consistent exercise that produces fitness, having some fun in life, and dietary supplements that work directly with the gene signals within bones to foster health and build strong bone - naturally. It is time that we as a culture put to rest the barbaric use of toxins that do nothing but bolster the profits of Big Pharma at the expense of human health.
Other Feature Articles:
In an unprecedented change of posture the New England Journal of Medicine has reversed itself on the issue of whether Vytorin causes cancer. In the initial release of data back in July NEJM stood by Merck and Schering-Plough, who hired an Oxford consultant to rule that a 50% statistically significant increased risk of cancer was by chance. I pointed out in an earlier posting that such statistical manipulation, based primarily on the opinion of the Oxford reviewer, was ridiculous. NEJM has had a sudden change of heart and now agrees with me.
The shocking death of Tim Russert last Friday has left an entire nation wondering what happened. He was a model patient, doing everything his doctors asked. All major media have run articles trying to explain the nuances and difficulties in treating coronary artery disease. These articles find little fault in Russert’s care, trying to create the idea that his heart attack was just too hard to predict and that all that could have been done for him was done. I beg to differ. His death represents the failure of standard medical care to produce a positive result – an occurrence that is all too common in today’s world.
Legions of well wishers look on as Senator Ted Kennedy struggles for his life, fighting against one of the most difficult types of brain tumors. Ironically, it may be the drugs he has so adamantly promoted that are the straw that broke the camel’s back, leading to his brain tumor.
The latest stone thrown at the 200-billion-dollar-a-year cell phone industry came from a study by neurosurgeon Vini G. Khurana entitled Mobile Phone-Brain Tumour: Public Health Advisory. His meta-analysis of existing cell phone studies may not contain a lot of new information; but his rather alarming message was carried by media around the world: “there is a growing body of statistically significant evidence for a relationship between the overall length of use of a mobile phone and the delayed occurrence of a brain tumor on the same side of the head as the ‘preferred side’ for mobile phone usage.” He claimed a 2-4 fold increased risk following 10 years of regular use.
On April 2, 2008 CNN spent the day bringing awareness to the problem of autism. Larry King’s segment, which included Jenny McCarthy along with a panel of guests, was particularly enlightening. My hat is off to Jenny, a celebrity mother who is making it quite uncomfortable for the Center for Disease Control (CDC) to ignore parents of autistic children seeking answers. Why does a mom have to do the work of the CDC? The answer is rather simple: our government’s zeal to insist on too many vaccines while ignoring the actual risks is the driving force behind the autism tragedy.
The Senate is about to approve legislation (Mothers Act – S.1375) which mandates the indoctrination of pregnant and nursing mothers into the use of extremely dangerous psychiatric medication. We already know this class of medication poses serious health risks to both mother and baby. Consequences to the baby are now proven to cause nerve-related changes that can adversely affect health for a lifetime.
Immediate Consumer Action is Needed to Stop Mothers Act The Mothers Act is pending legislation that will indoctrinate hundreds of thousands of mothers into taking dangerous psych drugs. It is a great example of how the Big Pharma lobby controls Congress to the detriment of health, as well as needlessly and dramatically inflating the costs of our health care system for everyone. Like any piece of legislation it purports to address a troubling issue – in this case the mood distress of mothers following birth known as postpartum depression. It is true that 10% - 15% of women need some assistance in dealing with this topic – but the majority of them sure don’t need it from Big Pharma. That is the Big Lie.
It now appears that the FDA Chief Andrew von Eschenbach, M.D. has committed perjury before Congress. Unlike Roger Clemens, who also seems to be putting his foot in his mouth before Congress, von Eschenbach’s actions appeared to have allowed unnecessary deaths to Americans – hardly the mission of the FDA. By contrast, Roger Clemens is simply causing death to his own reputation. Hopefully Congress can quit wasting taxpayer money on baseball and get to the bottom of what is really going on at the FDA.
Several high profile human cardiovascular drug experiments have turned into disasters for Big Pharma. These findings are sure to shake the misguided consumer confidence in drugs as a mainstay of preventive cardiovascular health. Hanging in the balance are billions of dollars of fraudulent drug sales based on the flimsy argument that changing numbers (blood sugar, cholesterol, or blood pressure) with the use of toxic drugs is somehow the same as actually being healthy…
Women across the country are being duped to consume billions of dollars worth of bone poisons under the false pretense that if they take them long enough they will not develop osteoporosis. Even the FDA is becoming alarmed by the side effects of these bone drugs. The biggest selling drug in this class is called Fosamax, made by Merck – the very same company that killed thousands of Americans with Vioxx while hiding cardiovascular risks from the FDA and patients. Does anyone trust them?…
Considering that tens of millions of Americans now take statins to lower cholesterol, the following headline was conspicuously absent from the major media this month: “Statins Found to Turn On Gene that Causes Muscle Damage.” It’s now a fact of science; a new study shows that taking statins destroys your muscle to a greater or lesser degree. And let’s not forget that the heart is a muscle.
On November 29, 2007 the FDA made a rather surprising, almost honest announcement. It said that it could not protect Americans from the dangers of drugs. A 56-page report by its Subcommittee on Science and Technology stated the FDA “suffers from serious scientific deficiencies and is not positioned to meet current or emerging regulatory responsibilities.” This blistering report on the life-threatening shortcomings of the FDA was released with the stamp of approval of the head of the FDA, Commissioner Andrew von Eschenbach. The flagrant disregard for human health by the FDA…
Oprah has done an immense favor to millions of American women by helping them understand that a malfunctioning thyroid gland may indeed be part of their weight and health problems. After writing openly about her thyroid problem in the October 2007 Oprah Magazine, she then went into the nature of thyroid problems on her TV show.
The United States Health Freedom Assembly met October 12 – 14, 2007 at the William Mitchell College of Law in Saint Paul, MN, a gathering of many of the top state, federal, and international health freedom advocates, organizations, and industry. The meeting took on a tone of extreme importance as the FDA has issued policy and obtained broad new regulatory authority over health freedom in the past 12 months. The FDA is seeking to undermine the law known as DSHEA (Dietary Supplement Health and Education Act of 1994), the cornerstone of health freedom in America. Emboldened by its new powers the FDA is now poised to trample the first amendment rights of companies and Americans who seek to explain or understand how nutrition can support health. The FDA campaign has begun.
On Wednesday, July 11, 2007 the House passed HR.2900 without allowing the Ron Paul (R-TX) amendments to protect dietary supplements. Representatives Frank Pallone, Jr. (D-NJ), John Dingell (D-MI), Henry Waxman (D-CA), and others falsely proclaimed that they were doing America a favor by passing this sweeping FDA-supported legislation that grants the rouge agency more power and money, and even transforms it into a quasi drug company.
The FDA, emboldened by its transformation into a drug company, has embarked upon an anti-American plan of interfering with business and intentionally eliminating various dietary supplement companies from the market. The FDA announcement came on Friday, June 22, 2007 under the guise of a final rule for dietary supplement good manufacturing practices (CGMPs). Within this 800 page rule the FDA states, “We find that this final rule will have a significant economic impact on a substantial number of small entities.... Establishments with above average costs, and even establishments with average costs, could be hard pressed to continue to operate. Some of these may decide it is too costly and either change product lines or go out of business.... 140 very small [less than 20 employees] and 32 small dietary supplement manufacturers [less than 500 employees] will be at risk of going out of business.... costs per establishment are proportionally higher for very small than for large establishments....The regulatory costs of this final rule will also discourage new small businesses from entering the industry.”
Under the false pretense of improved food and drug safety the FDA is re-inventing itself as a kingpin drug company. This charade has so far hoodwinked virtually all members of Congress. The Senate has already approved this FDA transformation. The House will bring similar legislation out of committee next week, with a vote in the full House likely in July.
The Andrew von Eschenbach FDA era is upon us. The Avandia scandal is the tip of the iceberg. Is anyone ready? The words “illicit financial collusion” have been replaced by the politically correct term, “collaboration.”
The penalty in China is death, in America its business as usual. Zheng Xiaoyu, the former head of China’s FDA, was sentenced to death for accepting $832,000 in drug company bribes and for dereliction of duty. Like China, our country is in the middle of a drug and food safety crisis. Why is FDA Commissioner Andrew von Eschenbach, M.D. getting a free pass? Why did the Senate just pass legislation (S.1082) that gives von Eschenbach significantly more power to do whatever he pleases? And exactly what is it that von Eschenbach is doing?
Senate Attempts Damage Control – House Braces for Onslaught Senators were taken off guard by the public outrage over the passing of bill S.1082 with language that can be used to seriously harass dietary supplements by enabling the FDA to apply drug-related risk analysis to the safety of food and food ingredients (and thus dietary supplements).
The FDA is Acquiring New Powers to Suppress Alternative Health Your right to have free access to safe and highly effective dietary supplements is under an intense multi-pronged FDA attack. On May 14, 2007 the Supreme Court sided with the FDA by deciding not to hear the case of Nutraceutical v FDA, letting stand a federal appeals court ruling that permits the FDA to use drug-related risk/ benefit analysis to determine if a nutrient is safe.
The Senate has sold out the American people. Anyone voting for change in the last election can now plainly see the shenanigans of a Democratic-controlled Senate. Under Republicans no FDA reform ever took place. Big Pharma owns so many Republicans that all meaningful legislation to curtail the deaths and injuries of American citizens at the hands of Big Pharma and the FDA had been completely thwarted for the past six years. Under Democratic control sweeping FDA reform favorable to Big Pharma was proposed and the majority of meaningful reform was blocked or seriously watered down. Which is worse? As Kennedy stated in his opening remarks today, S1082 (the Kennedy/Enzi FDA bill) was an “elaborate scheme.”
For approximately four days Americans lived in a delusional state that they may soon pay drug prices the same as every other country in the civilized world. Euphoria over breaking the Big Pharma monopoly turned to disgust as the chameleon, Senator Edward Kennedy (D-MA), changed sides and lead a contingency of Democrats against fellow Democrats lead by Byron Dorgan (D-ND). By passing the Cochran amendment the Dorgan amendment is poisoned and will no longer be effective. Maybe Democrats are now learning what Republicans have known for some time – you can’t trust Kennedy.
In May of 2006, after months of research and investigation, I published my ominous findings in the book Fight for Your Health: Exposing the FDA’s Betrayal of America. Everything I predicted in this book is on the fast track to becoming reality. A majority of Americans, not informed on current events and unaware of the history involved, are silent. Mainstream media, one of Big Pharma’s largest clients, is silent. Only the power of the internet, which rivals the invention of the printing press in significance, is making it possible for individuals to understand what is going on.
There is still time to stop FDA, Inc. Bill S1082 is a bill that helps fund the FDA with Big Pharma money. It is known all over Capital Hill as Big Pharma-designed legislation. It is running into all sorts of credibility problems. A vote is likely on Monday – delayed due to all the opposition flooding the Senate by “we the people.”
S1082 Update – Tuesday’s Activity. Fight Erupts on Senate floor: As the Senate continues to debate the Big Pharma-friendly sweeping reform of the FDA a new problem for Big Pharma’s prize Senators has erupted and quickly turned into confrontation on the floor of the Senate. At stake is at least 10 billion dollars per year in exorbitant Big Pharma profits. In one corner is Big Pharma-puppet Orrin Hatch (R-UT), representing the Kennedy/Enzi drug cartel. In the other corner is a majority of Senators lead by Byron Dorgan (D-ND).
The combination of a lack of sun and cold weather invariably strains your mood as well as your metabolism. It is an energy-depleting form of stress, similar to having a daily argument with someone. If your energy systems…
S1082 Update – Monday’s Activity at the bottom of this article. Bill S1082: The Food and Drug Administration Revitalization Act (also called the Prescription Drug User Fee Act of 2007) is one of the greatest scams and con jobs ever foisted on the American public. Current FDA management is grossly incompetent on the subject of drug safety.
A new attack against health freedom, drug safety, and dietary supplements was launched last week by Senator Edward Kennedy (D-MA) with major support from Michael Enzi (R-WY). It is called the Food and Drug Administration Revitalization Act (S1082). This legislation was planned over the past few years working hand-in-glove with the FDA’s dysfunctional management and legal team – meaning this legislation was written for the profits of Big Pharma and Big Biotech AT THE EXPENSE OF SAFETY AND HUMAN HEALTH.
Americans are up in arms that our pets are being injured and killed by a toxin sent to America by a Chinese company. Melamine, a toxic fertilizer used in China, is the suspected culprit behind the deaths and injuries to potentially hundreds of thousands of our pets. The FDA assures us that this toxin has not entered the human food supply – does anyone believe in the competence of the FDA? It is only a matter of time before this type of problem happens to humans, as the inept FDA has no control over imported food intended for humans, let alone pets.
On February 13, 2007 the House Energy and Commerce Committee’s Subcommittee on Oversight and Investigations opened hearings lambasting the FDA regarding the safety of drugs. The opening statement by Chairman John Dingell (D-MI) set the tone, “It is clear … that the FDA is badly broken. I expect that before we finish this investigation, which is just getting underway, we will discover whether the problems we have found are due to the work of scoundrels, irrational penny-pinching, or because the doors to the FDA “hen house” have been thrown open to foxes. It may be a combination of all three.”
Wall Street, international bankers, President Bush, pharmaceutical companies, new biotech companies, the Rockefeller empire, and the FDA have created a new plan for public health. It is a grand vision based on profit. It will use the FDA and, as needed, the Department of Homeland Security as the regulatory police force that ensures compliance in the name of public safety. Legitimate objections may be overpowered in the name of national security.
|
| Home > Health News > The Politics Of Health: Feature Article |